Article · Wikipedia archive · Last revised Jul 17, 2026

7-APB

7-(2-Aminopropyl)benzofuran (7-APB) is a monoamine releasing agent and designer drug of the benzofuran family, albeit with a potency an order of magnitude less than 6-APB. It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA). The drug was detected as a novel designer drug, in Europe, by 2013.

Last revised
Jul 17, 2026
Read time
≈ 1 min
Length
174 w
Citations
6
Source
Wikipedia ↗
7-APB
Clinical data
Other names7-(2-Aminopropyl)benzofuran; 7-APB
Drug classSerotonin–norepinephrine–dopamine releasing agent (SNDRA)1
Identifiers
  • 1-(1-benzofuran-7-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H13NO
Molar mass175.231 g·mol−1
3D model (JSmol)
  • CC(CC1=CC=CC2=C1OC=C2)N
  • InChI=1S/C11H13NO/c1-8(12)7-10-4-2-3-9-5-6-13-11(9)10/h2-6,8H,7,12H2,1H3
  • Key:YVMDMFRZSDUZLK-UHFFFAOYSA-N

7-(2-Aminopropyl)benzofuran (7-APB) is a monoamine releasing agent and designer drug of the benzofuran family, albeit with a potency an order of magnitude less than 6-APB.12 It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA).12 The drug was detected as a novel designer drug, in Europe, by 2013.3

See also

See also

References

References

  1. Rickli A, Kopf S, Hoener MC, Liechti ME (July 2015). "Pharmacological profile of novel psychoactive benzofurans". British Journal of Pharmacology. 172 (13): 3412–3425. doi:10.1111/bph.13128. PMC 4500375. PMID 25765500.
  2. Simmler LD, Liechti ME (2018). "Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances". Handbook of Experimental Pharmacology. Vol. 252. pp. 143–164. doi:10.1007/164_2018_113. ISBN 978-3-030-10560-0. PMID 29633178.
  3. Stanczuk A, Morris N, Gardner EA, Kavanagh P (April 2013). "Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in internet purchased products". Drug Testing and Analysis. 5 (4): 270–276. doi:10.1002/dta.1451. PMID 23349125.
External links